Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

With enough supplies, Israel looks to re-route AstraZeneca vaccine delivery

Wed, 21st Apr 2021 10:45

* Israel bought enough vaccine from others, official says

* Seeks to divert AstraZeneca shipment to other countries

* Israel's vaccine rollout one of the fastest in the world

JERUSALEM, April 21 (Reuters) - Israel no longer wants
AstraZeneca's COVID-19 vaccine and is exploring with the
company whether a big shipment in the pipeline could be sent
elsewhere, Israel's pandemic coordinator said on Wednesday.

"We are trying to find the best solution. After all, we
don't want (the vaccines) to get here and have to throw them
into the trash," the official, Nachman Ash, told Army Radio,
saying Israel's needs were being met by other suppliers.

In his remarks, Ash made no reference to AstraZeneca’s
vaccine having been associated with very rare blood clots in
Europe. Many countries there resumed administering it after the
European Union's drug watchdog said benefits outweighed risks.

Israel cast a wide net last year when trying to secure
vaccine doses at the height of the pandemic and pre-ordered from
a number of companies.

It largely settled on the Pfizer/BioNTech
vaccine, launching one of the world's swiftest rollouts.
COVID-19 infections in Israel have dropped dramatically and the
economy has reopened.

Israel is also buying the COVID-19 vaccines from Moderna
, which uses a similar messenger RNA (mRNA) technology.

Ash said that with supplies secure through 2022, Israel no
longer required the 10 million doses it agreed to purchase from
AstraZeneca.

"They can certainly be used in other places in the world. At
the moment, we are trying to find, along with the company, the
best way to do this," he said.

"We believe it would be best if they (the vaccines) did not
come to Israel and we agree with the company on some sort of way
to divert them elsewhere."

Officials at AstraZeneca had no immediate comment.

Around 81% of Israeli citizens or residents over 16 - the
age group eligible for the Pfizer/BioNTech vaccine in Israel -
have received both doses.

Some 167,000 of the 5.2 million Palestinians in the occupied
West Bank and Islamist Hamas-run Gaza have had at least one dose
of vaccine, with supplies coming in from Israel, Russia, the
United Arab Emirates, the global COVAX vaccine-sharing programme
and China.
(Reporting by Jeffrey Heller and Ari Rabinovitch. Editing by
Mark Potter)

More News
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.